Drug discovery – How is India doing? : Mr J B Gupta

The DIA’s three-day 8th Annual Conference on October 24, 2013, at the NIMHANS Convention Center, Bangalore, hosted a session focused on India as a drug innovation and delivery hub.


Mr J B Gupta, Senior VP, GVK Biosciences

Titled, ‘Drug Discovery - How is India doing?', the topic was presented by Mr J B Gupta, Senior VP, GVK Biosciences.

In his presentation, Mr Gupta presented the major milestones achieved based on which drug discovery progress is measured.

He mentioned the following milestones: Post TRIPS and focus on drug discovery (1994); out-licensing of proprietary molecules (1998); discover progress collaboration (2003); and launch of proprietary molecules (2012).

He said, "Drug discovery process and expertise should address the issues and challenges. When there is an unmet need, you need to understand the disease pathology, and then you discover a molecule and carry out trials."

Mr Gupta said that new drug R&D has been started by several Indian pharma companies but it has been very difficult to discover a molecule up to the launch.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email